The cost of generic Linzess is not yet established as the drug, linaclotide, is still under patent protection. Linzess is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) [1].
When does Linzess patent expire?
Linzess (linaclotide) is protected by several patents. While the exact expiration dates can vary due to challenges and extensions, initial patent protection for linaclotide was expected to last until at least 2025 [2]. However, the landscape of drug patents is complex and subject to legal challenges and market exclusivities, which can influence the availability of generics [3]. Information on specific patent expiry dates and any potential for earlier generic entry can be tracked through resources like DrugPatentWatch.com [2].
How much does Linzess currently cost?
Currently, as Linzess is a branded medication without generic alternatives, its cost can be significant. The price can vary based on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply can range from several hundred dollars to over $400 [1]. Patients often utilize manufacturer coupons or patient assistance programs to help offset these costs [1].
What are the alternatives to Linzess?
Several other medications are available to treat IBS-C and CIC, offering alternatives for patients. These include other prescription drugs and over-the-counter options. Some prescription alternatives work by different mechanisms, such as acting as secretagogues to increase fluid secretion in the intestines or as guanylate cyclase-C agonists similar to linaclotide. Over-the-counter options may include fiber supplements or laxatives [4].
How do generics become available after patent expiry?
After a drug's patents expire, and any applicable market exclusivities conclude, other pharmaceutical companies can apply to the U.S. Food and Drug Administration (FDA) for approval to manufacture and sell generic versions. The FDA reviews these applications to ensure the generic drug is bioequivalent and has the same active ingredient, dosage form, strength, and route of administration as the brand-name drug [5]. The availability of generic versions typically leads to a substantial decrease in price compared to the brand-name medication.
What is the mechanism of action for Linzess?
Linzess works by activating guanylate cyclase-C (GC-C) on the luminal surface of the intestinal epithelium. This activation increases intracellular cyclic guanosine monophosphate (cGMP), which in turn reduces fluid secretion and transit throughout the intestine. By modulating these processes, linaclotide helps to alleviate symptoms of constipation and abdominal pain associated with IBS-C and CIC [1].
What are the potential side effects of Linzess?
The most common side effect of Linzess is diarrhea [1]. Other potential side effects can include abdominal pain, bloating, and flatulence. Patients experiencing severe or persistent diarrhea should consult their healthcare provider. Linzess carries a boxed warning regarding the risk of serious dehydration in pediatric patients, and it is contraindicated in patients under 6 years of age [1].
Sources:
1. https://www.goodrx.com/linzess
2. https://www.drugpatentwatch.com/
3. https://www.fda.gov/
4. https://www.mayoclinic.org/
5. https://www.ncbi.nlm.nih.gov/